Czech Republic Ewopharma’s Jan Krejčí, Country Manager for the Czech affiliate for the last eight years, shares the achievements of the company in its two main business pillars, prescription drugs, and consumer healthcare, and the successful entry into the hospital segment through the challenging and rewarding journey launching Santhera’s orphan drug for…
China Jens Ewert, Life Science and Health Care Industry Leader at Deloitte China, shares his perspectives on the growth of China’s Life Sciences and Healthcare market, the strong presence of Deloitte within China as a consulting firm, the recent trends of the market and their commitment to delivering comprehensive solutions to…
UAE Mohamed Galal, VP and Head of Bayer’s Consumer Health Division in the Middle East, draws upon his 16 years of experience with the company to discuss their digitalization approach to position themselves as the partner of choice. Moreover, he reveals how the UAE is taking an innovative approach to addressing…
Puerto Rico When life sciences companies decide to transfer the production of new drug to Puerto Rico, extend an existing production line, or simply sustain existing operations, they can count on the support of a vast network of service providers with unmatched expertise in quality and regulatory compliance, from premarket approval (PMA)…
Hungary Dr. András Szabó, CEO of Szinapszis, a Hungarian market research and consulting agency specialized in the health industry, offers his expert insights on the key challenges and trends shaping the country’s pharma and healthcare ecosystem. Furthermore, Szabó highlights the offering Szinapszis can deliver as a partner of choice to both…
Korea Multinational pharma company managers working abroad must adapt to new cultures and develop a deep understanding of local markets. Korea is no different; here three foreign country managers give their first impressions and insights into the Korean pharma market. Nic Horridge, Roche As a newcomer in the land…
Consulting PharMaCon is a marketing, communications and advertising agency specialized in the pharmaceutical and healthcare industry for the Latin American and Hispanic US market. CEO and founder, Ivelisse Casillas, explains the advantages of being a pharma and healthcare-focused company, and their strategy to conquer the US Hispanic market. One of…
GSK In conversation at the FT Global Pharmaceutical and Biotechnology Conference in London,* an energetic Emma Walmsley discussed the strategic and cultural shifts she has implemented in her two and a half years as CEO of iconic British firm GSK, the increasingly important intersection between technology and pharma, and countering the…
Sweden With almost three decades of experience in the Swedish life science industry, Jan Hellqvist, general manager of KLIFO in Sweden, explains why the country has seen the number of clinical studies from small and medium size companies skyrocket in recent years. Moreover, he discusses the possibilities of opening KLIFO’s affiliate…
Opinion Anthony Harrington of global investment banking and asset management firm Alantra outlines why healthcare and consulting communications companies are increasingly attractive targets for private equity. The supply of PE money chasing fewer and fewer assets is only going to increase the attraction of healthcare communications and consulting firms to…
Europe Awareness is growing of the dangers of healthcare-associated infections (HAIs) in Europe, and conversations are beginning to taking place around how to leverage data to combat these infections and antimicrobial resistance (AMR). A panel of experts from diverse backgrounds at the European Health Forum Gastein put their heads together to…
China Mike Braun, partner at Deloitte China, shares his perspectives on the recent China reforms, the strong presence of Deloitte within China as a consulting firm with a DNA in professional services, the importance of the healthcare and life sciences industry to their business here, and their commitment to delivering comprehensive…
See our Cookie Privacy Policy Here